SPINAL-CORD METABOLISM OF THE 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED MONKEY

被引：5

|

作者：

SCHWARTZMAN, RJ

ALEXANDER, GM

机构：

来源：

BRAIN RESEARCH | 1985年 / 337卷 / 02期

关键词：

D O I：

10.1016/0006-8993(85)90062-9

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

收藏

页码：263 / 268

页数：6

相关论文

共 50 条

[41] CHANGES OF THE CONVULSANT RESPONSE IN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)-TREATED RODENTS
FARIELLO, RG
DEMATTEI, M
GOLDEN, GT
FERRARO, TN
NEUROLOGY, 1986, 36 (04) : 96 - 97
[42] Levodopa-induced hyperactivity in mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Nicholas, Anthony P.
MOVEMENT DISORDERS, 2007, 22 (01) : 99 - 104
[43] Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice
Turmel, H
Hartmann, A
Parain, K
Douhou, A
Srinivasan, A
Agid, Y
Hirsch, EC
MOVEMENT DISORDERS, 2001, 16 (02) : 185 - 189
[44] EFFECTS OF AGE ON GM1 GANGLIOSIDE-INDUCED RECOVERY OF CONCENTRATIONS OF DOPAMINE IN THE STRIATUM IN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-TREATED MICE
SCHNEIDER, JS
NEUROPHARMACOLOGY, 1992, 31 (02) : 185 - 192
[45] The effects of a selective dopamine D2 receptor agonist on behavioral and pathological outcome in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated squirrel monkeys
Stephenson, DT
Meglasson, MD
Connell, MA
Childs, MA
Hajos-Korcsok, E
Emborg, ME
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (03): : 1257 - 1266
[46] TNFR2 mediated TNF-α signaling and NF-κB activation in hippocampus of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice
Ghosh, Nabanita
Mitra, Soham
Sinha, Priyobrata
Chakrabarti, Nilkanta
Bhattacharyya, Arindam
NEUROSCIENCE RESEARCH, 2018, 137 : 36 - 42
[47] Lentiviral delivery of glial cell line-derived neurotrophic factor in aged 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys
Emborg, Marina E.
Roitberg, Ben Z.
Moirano, Jeffrey
Zufferey, Romaine
Ebert, Allison D.
Joers, Valerie
Holden, James
Converse, Alexander K.
Koprich, James B.
Kordower, Jeffrey H.
Aebischer, Patrick
NEUROSURGERY, 2006, 59 (02) : 481 - 482
[48] STUDIES ON THE METABOLISM AND TOXICITY OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE IN CULTURES OF EMBRYONIC RAT MESENCEPHALON
MYTILINEOU, C
FRIEDMAN, L
JOURNAL OF NEUROCHEMISTRY, 1988, 51 (03) : 750 - 755
[49] STUDIES ON THE MECHANISM OF ACTION OF 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP)
COHEN, G
MYTILINEOU, C
LIFE SCIENCES, 1985, 36 (03) : 237 - 242
[50] Blockade of cannabinoid type 1 receptors augments the antiparkinsonian action of levodopa without affecting dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys
Cao, Xuebing
Liang, Li
Hadcock, John R.
Iredale, Philip A.
Griffith, David A.
Menniti, Frank S.
Factor, Stewart
Greenamyre, J. Timothy
Papa, Stella M.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 323 (01): : 318 - 326

← 1 2 3 4 5 →